Sugi Predict

Sugi Predict / Compounds / SCHEMBL1764971

SCHEMBL1764971

SCHEMBL1764971

CCOC(=O)c1cc(-c2cc(F)cc(C#N)c2)n(-c2cccc(Cl)c2)n1

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 3/20 0.48
▸ LMNA P02545 1/20 0.48
▸ CHRNA7 P36544 3/20 0.48
▸ FAAH O00519 5/20 0.46
▸ MGLL Q99685 2/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ PPP1CA P62136 1/20 0.45
▸ CA9 Q16790 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ GABRA2 P47869 1/20 0.45
▸ GABRB2 P47870 1/20 0.45
▸ THRB P10828 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ PGR P06401 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1765446 0.93 CHRNA7 (0.49) TP53CHRNA7FAAHMGLLCA9
SCHEMBL1764994 0.90 TP53 (0.55) TP53LMNACHRNA7FAAHMGLL
SCHEMBL1765413 0.90 CHRNA7 (0.47) TP53LMNACHRNA7FAAHMGLL
SCHEMBL1765054 0.90 CHRNA7 (0.49) TP53CHRNA7FAAHMGLLPPP1CA
SCHEMBL2193884 0.89 TP53 (0.52) TP53LMNACHRNA7FAAHMGLL
SCHEMBL1764878 0.88 TP53 (0.53) TP53LMNACHRNA7FAAHMGLL
SCHEMBL1765003 0.88 TP53 (0.52) TP53LMNACHRNA7FAAHMGLL
SCHEMBL1764882 0.87 CHRNA7 (0.50) TP53CHRNA7FAAHMGLLCA9
SCHEMBL1765262 0.87 TP53 (0.52) TP53LMNACHRNA7FAAHMGLL
SCHEMBL3433370 0.85 ALDH1A1 (0.41) TP53LMNACHRNA7ALDH1A1PPP1CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399682-B2 Substituted (pyrazolylcarbonyl)imidazolidinones and their use AICURIS GMBH & CO. KG (DE) 2013-03-19 — — US disclosed
US-8399682-B2 Substituted (pyrazolylcarbonyl)imidazolidinones and their use AICURIS GMBH & CO. KG (DE) 2013-03-19 — — US disclosed
US-8399682-B2 Substituted (pyrazolylcarbonyl)imidazolidinones and their use AICURIS GMBH & CO. KG (DE) 2013-03-19 — — US disclosed
US-20110124618-A1 SUBSTITUTED (PYRAZOLYLCARBONYL)IMIDAZOLIDINONES AND THEIR USE AICURIS GMBH & CO. KG (DE) 2011-05-26 — — US disclosed
US-20110124618-A1 SUBSTITUTED (PYRAZOLYLCARBONYL)IMIDAZOLIDINONES AND THEIR USE AICURIS GMBH & CO. KG (DE) 2011-05-26 — — US disclosed
US-20110124618-A1 SUBSTITUTED (PYRAZOLYLCARBONYL)IMIDAZOLIDINONES AND THEIR USE AICURIS GMBH & CO. KG (DE) 2011-05-26 — — US disclosed
WO-2009115213-A1 (PYRAZOLYL CARBONYL)IMIDAZOLIDINONE DERIVATIVES FOR THE TREATMENT OF RETROVIRAL DISEASES AICURIS GMBH & CO. KG (DE) 2009-09-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110124618-A1 SUBSTITUTED (PYRAZOLYLCARBONYL)IMIDAZOLIDINONES AND THEIR USE TPMT, PAICS, THPO TP53 1099/4885LMNA 1298/4885CHRNA7 3365/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.